“…The 10 RCTs enrolled a total of 472 participants, (321 women [68%] and 135 men [32%]), of which 254 (54%) received the TTNS treatment. Thirty six participants in control groups received inactive sham (18%), 142 (56%) received anticholinergic drugs (solifenacin succinate [49, 19%], oxybutynin immediate release [10, 4%], and extended release [84, 33%]) bladder training and pelvic floor muscles training (26, 10%), stretching exercises (12, 5%), sacral foramina transcutaneous electrical stimulation, or no treatment (9, 4%) . Five RCTs were conducted only on women, one on men only and four included mixed sex samples .…”